COMMUNIQUÉS West-GlobeNewswire

CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
17/07/2026
CAMBRIDGE, Mass., July 17, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting [...]
Zentalis Pharmaceuticals to Present at the European Society for Medical Oncology (ESMO) Congress 2026
17/07/2026
Rapid oral presentation to highlight overall survival data from the DENALI Part 1b study of azenosertib SAN DIEGO, July 17, 2026 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology [...]
Vaxart Announces Results of Annual Meeting of Stockholders
17/07/2026
SOUTH SAN FRANCISCO, Calif., July 17, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based [...]
Immuneering Corporation Announces Grants of Inducement Awards
17/07/2026
NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, previously announced on June [...]
Cosmos Health Share Buyback Expands to 5.11 Million Shares; Continues Open Market Repurchases
17/07/2026
CHICAGO, July 17, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced that it has repurchased an [...]
DBV Technologies Files At-The-Market (ATM) Prospectus for Up to $150 Million of Sales
17/07/2026
Châtillon, France, July 17, 2026 DBV Technologies Files At-The-Market (ATM) Prospectus for Up to $150 Million of Sales DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Capital Market: DBVT) (the “Company [...]
DBV Technologies dépose un prospectus relatif à son Programme At-The-Market (ATM) pour un montant pouvant atteindre 150 millions de dollars
17/07/2026
Châtillon, France, le 17 juillet 2026 DBV Technologies dépose un prospectus relatif à son Programme At-The-Market (ATM) pour un montant pouvant atteindre 150 millions de dollars DBV Technologies (Euronext : DBV – ISIN [...]
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17/07/2026
WALTHAM, Mass., July 17, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and [...]
Report on Carbios’ liquidity contract
17/07/2026
REGULATED INFORMATION: ONGOING Shares concerned: Carbios (ISIN code: FR0011648716) / Market concerned: Euronext Growth Paris Clermont-Ferrand (France), 17 July 2026 (18:00 CEST). CARBIOS , (Euronext Growth Paris: ALCRB [...]
CARBIOS : Bilan semestriel du contrat de liquidité
17/07/2026
INFORMATION REGLEMENTEE : PERMANENTE Titre concerné : CARBIOS (code ISIN FR0011648716) / Marché concerné : Euronext Growth Paris Clermont-Ferrand (France), le 17 juillet 2026 (18h00 CEST). CARBIOS présente le bilan [...]
Skyline LASIK Introduces WaveLight® Plus LASIK, Advancing Precision in Vision Correction
17/07/2026
New data presented at the American Academy of Ophthalmology highlights enhanced visual outcomes with next-generation LASIK technology Colorado Springs, CO, July 17, 2026 (GLOBE NEWSWIRE) -- Skyline LASIK is proud to [...]
SS Innovations To Showcase the SSi Mantra Surgical Robotic System at SRS 2026
17/07/2026
Company’s advanced surgical robotic system will be on display, spotlighted in multiple breakout sessions, and featured in a kidney telesurgery to be broadcast live at the premier industry event FORT LAUDERDALE, Fla., [...]
Sienna Announces Long-Term Care Redevelopment in Greater Toronto Area
17/07/2026
MARKHAM, Ontario, July 17, 2026 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (" Sienna " or the " Company ") (TSX: SIA) announced today that it will proceed with its next redevelopment project in the Greater Toronto [...]
SL Science Announces Successful Exhibition of Breakthrough Brain Cancer Therapy Research at the 2026 World Congress of Basic and Clinical Pharmacology
17/07/2026
Joint presentation with Taipei Medical University, JY BioMed, and HeXun Biosciences highlighted the power of gamma delta (γδ) T cells in eliminating glioblastoma in preclinical studies. TAIPEI, TAIWAN, July 17, 2026 ( [...]
Immatics Announces Upcoming Presentations Across Its PRAME Franchise at ESMO Congress 2026
17/07/2026
Houston, Texas and Tuebingen, Germany, July 17, 2026 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), the global leader in precision targeting of PRAME with multiple clinical-stage programs spanning cell [...]
ACTG Announces Behavioral Health and Implementation Study to Optimize Long-Acting HIV Treatment among People who have Struggled to Maintain HIV Suppression
17/07/2026
CHAPEL HILL, N.C., July 17, 2026 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the opening of A5432, a study assessing factors that may affect [...]
Glucotrack, Inc. and Lōkahi Therapeutics™ Announce Strategic Financing Support from E.F. Hutton & Co. in Connection with Their Recently Completed Business Combination and Future Capital Markets Initiatives
17/07/2026
RUTHERFORD, N.J. and SAN DIEGO, July 17, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack" or the "Company"), together with its operating business Lōkahi Therapeutics™ ("Lōkahi") , a clinical-stage [...]
Enovis to Host Second Quarter 2026 Results Conference Call on August 6th
17/07/2026
Dallas, TX, July 17, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to [...]
Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations
17/07/2026
Approval of iohexol injection 350 mg iodine/mL in 50 mL, 75 mL and 100 mL vials, and 300 mg iodine/mL in 50 mL vial, significantly expands Amneal’s injectable contrast portfolio Portfolio now positioned to address the [...]

Pages